Intravacc B.V. (The Institute for Translational Vaccinology, NL)

https://www.intravacc.nl

The Netherlands-based Intravacc is one of the world's leading institutes for translational vaccinology. As an established independent CDMO organization with many years of experience in the development and optimization of vaccines and vaccine technologies, Intravacc has transferred its technology all over the globe, including polio vaccines, measles vaccines, DPT vaccines, Hib vaccines, and influenza vaccines. Intravacc offers a wide range of expertise to independently develop vaccines from lead concept to clinical phase I/II studies for partners worldwide such as academia, public health organizations (WHO, BMGF), and biotech and pharmaceutical companies. *

	Start	2018-01-01 existent
	Industry	vaccine technology
	Industry 2	vaccine
	Person	Groen, Jan (Intravacc 202005– before Novigenix + MDxHealth/OncoMethylome CEO before Agendia + Focus Diagnostics)

	Region	Bilthoven
	Country	Netherlands
	Street	9 Antonie van Leeuwnhoeklaan Utrecht Science Park
	City	3721 MA Bilthoven
	Tel	+31-30-7920-300
		Address record changed: 2024-01-05

Basic data	Employees	D: 101 to 500 (2018-01-01)

		* Document for »About Section«: Intravacc B.V.. (9/8/20). "Press Release: Intravacc Receives US NIH/NIAID Contract to Develop Enterovirus D68 Vaccine". Bilthoven.

		Record changed: 2025-03-16